Clinicoimmunological rationale of interferon therapy in chronic bacterial prostatitis
- Authors: Kamalov AA1, Efremov EA1, Dorofeev SD1, Tret'yakov AA1, Okhobotov DA1, Mel'nik Y.I1, Bedretdinova DA1, Kamalov AA1, Efremov EA1, Dorofeev SD1, Tretiakov AA1, Okhobotov DA1, Melnik Y.I1, Bedretdinova DA1
-
Affiliations:
- Issue: No 1 (2010)
- Pages: 34-38
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277541
- ID: 277541
Cite item
Full Text
Abstract
Keywords
About the authors
A A Kamalov
E A Efremov
S D Dorofeev
A A Tret'yakov
D A Okhobotov
Ya I Mel'nik
D A Bedretdinova
A A Kamalov
E A Efremov
S D Dorofeev
A A Tretiakov
D A Okhobotov
Ya I Melnik
D A Bedretdinova
References
- McNaughton Collins M., MacDonald R., Wilt T. J. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann. Intern. Med. 2000; 133 (5): 367-381.
- Collins M. M., Barry M. J. Epidemiology of chronic prostatitis. Curr. Opin. Urol. 1998; 8 (1): 33-37.
- Diokno A. C. et al. Interstitial cystitis, gynecologic pelvic pain, prostatitis, and their epidemiology. Int. J. Urol. 2003; 10 (suppl.): S3-S6.
- Horcajada J. P. et al. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J. Antimicrob. Chemother. 2002; 49 (1): 55-59.
- Krieger J. N. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol. Nefrol. 2004; 56 (2): 99-107.
- Krieger J. N. et al. Epidemiology of prostatitis: new evidence for a world-wide problem. Wld J. Urol. 2003; 21 (2): 70-74.
- Krieger J. N., Ross S. O., Riley D. E. Chronic prostatitis: epidemiology and role of infection. Urology 2002; 60 (6, suppl.): 8- 12; discus.: 13.
- Drannik G. N. et al. Local immunity of chronic prostatitis patients. Vestn. Dermatol. 1986; 9: 66-70.
- Drannik G. N. et al. T and B. systems of immunity in patients with chronic prostatitis complicated by infertility. Urol. Nefrol. (Mosk.) 1986; 2: 59-61.
- Gus'kov A. R., Gorlina N. K., Simonova A. V. Chronic bacterial prostatitis as a manifestation of secondary immunodeficiency state. Zh. Mikrobiol. 1998; 3: 47-51.
- Kumon H. Detection of a local prostatic immune response to bacterial prostatitis. Infection 1992; 20 (suppl. 3): S236-S238.
- Leport C. et al. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J. Urol. (Baltimore) 1989; 141 (2): 334-336.
- Savitskaia K. I. et al. Immuno-microbiological aspects of chronic bacterial prostatitis pathogenesis. Vestn. Ros. Akad. Med. Nauk 1999; 2: 51-58.
- Guskov A. R., Gorlina N. K. Immunocorrection therapy in complex treatment of prostatitis. Rus. J. Immunol. 1998; 3 (2): 159- 166.
- Rodoman V. E. et al. Immunocorrection in the combined treatment of patients with chronic prostatitis. Vestn. Dermatol. 1983; 9: 69-72.
- Seregin S. P. et al. Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis. Urologia 2002; 4: 14-16.
- Ding X. G. et al. IFN-gamma and TGF-beta1, levels in the expressed prostatic secretions of patients with chronic abacterial prostatitis. Zhonghua Nan Ke Xue 2006; 12 (11): 982-984.
- Kalinina S. N., Tiktinskii O. L., Aleksandrov V. P. Clinicoimmunological disorders in patients with chronic prostatitis caused by latent urogenital infection. Urologia 2006; 3: 74-77, 79.
- Kodak J. A. et al. Activation of innate immunity by prostate specific antigen (PSA). Prostate 2006; 66 (15): 1592-1599.
- Liu H. H. et al. Detection of peripheral blood Th1/Th2 cell ratio in patients with chronic abacterial prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue 2006; 12 (4): 330-332, 336.
- Motrich R. D. et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin. Immunol. 2005; 116 (2): 149-157.
- Chen M., Lin Z., Cao X. Immunological mechanism of human alpha-interferon gene therapy for treatment of melanoma. Zhonghua Zheng Xing Wai Ke Za Zhi 2001; 17 (5): 306-308.
- Daines M. O., Hershey G. K. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J. Biol. Chem. 2002; 277 (12): 10387-10393.
- Kuhen K. L., Samuel C. E. Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. Virology 1999; 254 (1): 182-195.
- Tompkins W. A. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. J. Interferon Cytokine Res. 1999; 19 (8): 817-828.
- Benson P. J., Smith C. S. Cytomegalovirus prostatitis. Urology 1992; 40 (2): 165-167.
- Coombs R. W. et al. Lower genitourinary tract sources of seminal HIV. J. Acquir. Immune Defic. Syndr. 2006; 41 (4): 430-438.
- Dikov D., Chatelet F. P., Dimitrakov J. Pathologic features of necrotizing adenoviral prostatitis in an AIDS patient. Int. J. Surg. Pathol. 2005; 13 (2): 227-231.
- Doble A., Harris J. R., Taylor-Robinson D. Prostatodynia and herpes simplex virus infection. Urology 1991; 38 (3): 247-248.